New developments in antifungal strategy. - Wikidata - wikimedia - TriplyDB

New developments in antifungal strategy.

New developments in antifungal strategy.

http://www.wikidata.org/entity/Q35917388

about

Antifungal agents, WO2009025733.

P2860

Q37623837-AA4B7214-C8B6-487F-95A3-D8F521DE5027

P2860

New developments in antifungal strategy.

http://www.wikidata.org/entity/Q35917388

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

New developments in antifungal strategy.

@ast

New developments in antifungal strategy.

@en

type

label

New developments in antifungal strategy.

@ast

New developments in antifungal strategy.

@en

prefLabel

New developments in antifungal strategy.

@ast

New developments in antifungal strategy.

@en

P1433

Q35917388-E64D76EA-CCF8-4415-8D44-4DD6032D1486

P1476

Q35917388-CCD819C7-1287-4DF0-9DCB-220C86242731

P2093

Q35917388-99BB2AF7-0519-4E18-8C35-FBD2EA4EFC8D

Q35917388-ED08BAA6-0446-4196-AFF1-65A06DE16064

P2860

Q35917388-02F23118-3D20-4543-8A27-AECE5C07EF91

Q35917388-09FC327B-DEF2-47F4-9737-32139110BABB

Q35917388-19DC6922-FB11-48A7-928E-02825B8B7DF1

Q35917388-1E3E85CF-5C9D-4288-8DA3-6BDF58DD2AE6

Q35917388-2AA8EF5B-A23D-4CCD-9886-96E68E7613A8

Q35917388-335E7DE7-FB33-413F-B80F-176745832EA6

Q35917388-3ADA502A-F07A-4A17-BEB1-BA783FF1DB3E

Q35917388-3BDAE16D-E529-49E3-B37F-6335024BC374

Q35917388-595E0429-2C29-48F8-9348-6BE5EE1E2C7C

Q35917388-5B201EA2-6CF0-4CCA-B09F-8CDCFEA1D7FD

P304

Q35917388-F2DB19C2-10FE-4C4F-9F4D-58238F83F0E9

P31

Q35917388-27F846C8-3E25-4011-A335-A518ADEF3AAB

P356

Q35917388-37B1CEBC-F3B1-4B9A-860E-AFB3BB83E6B8

P433

Q35917388-EB258EAC-8F21-4D96-80E5-B5B47E0B6965

P478

Q35917388-E62B4E0D-5242-4BF4-A55D-DE9993CF31C4

P577

Q35917388-ACB07916-C2FA-425C-8826-0C2DF2119D14

P698

Q35917388-833FDBF4-7917-4F32-BD75-ED0390BD76AA

P356

14787210.2.2.269

P1433

Expert Review of Anti-infective Therapy

P1476

New developments in antifungal strategy.

@en

P2093

Anjali Shetty

http://www.w3.org/2001/XMLSchema#string

Rosemary A Barnes

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

Activities of sordarins in experimental models of candidiasis, aspergillosis, and pneumocystosis

Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial

The epidemiology of sepsis in the United States from 1979 through 2000

Pharmacology of itraconazole.

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.

Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases.

The exciting future of antifungal therapy.

P304

269-277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14787210.2.2.269

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15482192

http://www.w3.org/2001/XMLSchema#string